Caribou Biosciences, Inc.

Quick facts

Phase 2 pipeline

• Caribou-sponsored investigational therapy · Genetics, Gene Therapy
  This investigational therapy targets the CRISPR-Cas12 system to modulate gene expression.

Phase 1 pipeline

• CB-011

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Caribou Biosciences, Inc. portfolio CI brief
• Caribou Biosciences, Inc. pipeline updates RSS